Aap Implantate AG Announces 2024 Fiscal Year EBITDA and Postpones Financial Statements

aap Implantate AG has reported that its EBITDA for the fiscal year 2024 amounts to EUR -0.85 million, falling short of its initial forecast ranging between EUR -0.5 million and EUR 0.5 million. The discrepancy is attributed primarily to one-time charges included in the financial outcomes. Adjusted EBITDA, excluding these one-time effects, stands at EUR -0.2 million, aligning with prior expectations.

The company plans to release preliminary, unaudited financial figures for 2024 and audited annual financial statements on June 30, 2025. However, the finalized consolidated financial statements release has been deferred until July 2025. This delay is intended to ensure ample time for auditing processes, including ESEF tagging.